167
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Blood urea nitrogen/albumin ratio on admission predicts mortality in patients with non ST segment elevation myocardial infarction

, , ORCID Icon, , , & show all
Pages 454-460 | Received 29 Apr 2022, Accepted 01 Sep 2022, Published online: 20 Sep 2022

References

  • World Health Organization (WHO). Global health estimates 2016: estimated deaths by age, sex and cause. Geneva: WHO; 2018. http://www.who.int/healthinfo/global_burden_disease/estimates/en/
  • Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005;1(2):219–227.
  • Rognoni A, Cavallino C, Veia A, et al. Pathophysiology of atherosclerotic plaque development. Cardiovasc Hematol Agents Med Chem. 2015;13(1):10–13.
  • Hatmi ZN, Saeid AK, Broumand MA, et al. Multiple inflammatory prognostic factors in acute coronary syndromes: a prospective inception cohort study. Acta Medica Iranica. 2010;:51–57.
  • Ranzani OT, Zampieri FG, Forte DN, et al. C-reactive protein/albumin ratio predicts 90-day mortality of septic patients. PLoS One. 2013;8(3):e59321.
  • Karaman S, Coskun A. Do MCHC, MPV, and procalcitonin levels determine prognosis in acute coronary syndrome? Emerg Med Int. 2019;2019:6721279.
  • Horwich TB, Kalantar-Zadeh K, MacLellan RW, et al. Albumin levels predict survival in patients with systolic heart failure. Am Heart J. 2008;155(5):883–889.
  • Oduncu V, Erkol A, Karabay CY, et al. The prognostic value of serum albumin levels on admission in patients with acute ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention. Coron Artery Dis. 2013;24(2):88–94.
  • Richter B, Sulzgruber P, Koller L, et al. Blood urea nitrogen has additive value beyond estimated glomerular filtration rate for prediction of long-term mortality in patients with acute myocardial infarction. Eur J Intern Med. 2019;59:84–90.
  • Ryu S, Oh SK, Cho SU, et al. Utility of the blood urea nitrogen to serum albumin ratio as a prognostic factor of mortality in aspiration pneumonia patients. Am J Emerg Med. 2021;43:175–179.
  • Emami A, Javanmardi F, Rajaee M, et al. Predictive biomarkers for acute kidney injury in burn patients. J Burn Care Res. 2019;40(5):601–605.
  • Tatlisu MA, Kaya A, Keskin M, et al. The association of blood urea nitrogen levels with mortality in acute pulmonary embolism. J Crit Care. 2017;39:248–253.
  • Bevc S, Penko M, Kanic V, et al. Mortality of patients with renal dysfunction after percutaneous coronary intervention. Angiology. 2010;61(1):24–30.
  • Solomon SD, Pfeffer MA. Renin-angiotensin system and cardiac rupture after myocardial infarction. Circulation. 2002;106(17):2167–2169.
  • Xia B, Song B, Zhang J, et al. Prognostic value of blood urea nitrogen-to-serum albumin ratio for mortality of pneumonia in patients receiving glucocorticoids: Secondary analysis based on a retrospective cohort study. J Infect Chemother. 2022;28(6):767–773.
  • Peng X, Huang Y, Fu H, et al. Prognostic value of blood urea nitrogen to serum albumin ratio in ıntensive care unit patients with lung cancer. IJGM. 2021;14:7349–7359.
  • Lin Z, Zhao Y, Xiao L, et al. Blood urea nitrogen to serum albumin ratio as a new prognostic indicator in critical patients with chronic heart failure. ESC Heart Fail. 2022;9(2):1360–1369.
  • Caixeta A, Généreux P, Palmerini T, et al. Prognostic utility of the SYNTAX score in patients with single versus multivessel disease undergoing percutaneous coronary intervention (from the acute catheterization and urgent ıntervention triage StrategY [ACUITY] trial). Am J Cardiol. 2014;113(2):203–210.
  • Magro M, Nauta ST, Simsek C, et al. Usefulness of the SYNTAX score to predict ‘‘no reflow’’ in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Am J Cardiol. 2012;109(5):601–606.
  • Garg S, Sarno G, Serruys PW, et al. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute STsegment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (single High-Dose bolus tirofiban and Sirolimus-Eluting stent Versus abciximab and Bare-Metal stent in acute myocardial ınfarction) and MULTISTRATEGY (multicenter evaluation of single High-Dose bolus tirofiban Versus abciximab With Sirolimus-Eluting stent or Bare-Metal stent in acute myocardial ınfarction study) trials. JACC Cardiovasc Interv. 2011;4(1):66–75.
  • Madhavan MV, Généreux P, Rubin J, et al. Usefulness of the SYNTAX score to predict acute kidney injury after percutaneous coronary intervention (from the acute catheterization and urgent ıntervention triage strategy trial. Am J Cardiol. 2014;113(8):1331–1337. )
  • Scherff F, Vassalli G, Sürder D, et al. The SYNTAX score predicts early mortality risk in the elderly with acute coronary syndrome having primary PCI. J Invasive Cardiol. 2011;23(12):505–510.
  • Yadav M, Généreux P, Palmerini T, et al. SYNTAX score and the risk of stent thrombosis after percutaneous coronary intervention in patients with non-STsegment elevation acute coronary syndromes: An ACUITY trial substudy. Cathet Cardiovasc Intervent. 2015;85(1):1–10.
  • Kurtul A, Murat SN, Yarlioglues M, et al. Usefulness of serum albumin concentration to predict high coronary SYNTAX score and In-Hospital mortality in patients With acute coronary syndrome. Angiology. 2016;67(1):34–40.
  • Sharma K, Mogensen KM, Robinson MK. Pathophysiology of critical ıllness and role of nutrition. Nutr Clin Pract. 2019;34(1):12–22.
  • Usberti M, Federico S, Di Minno G, et al. Effects of angiotensin II on plasma ADH, prostaglandin synthesis, and water excretion in normal humans. Am J Physiol. 1985;248(2 Pt 2):F254–259.
  • Nicholson JP, Wolmarans MR, Park GR. The role of albumin in critical illness. Br J Anaesth. 2000;85(4):599–610.
  • Valgimigli M, Ceconi C, Malagutti P, et al. Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term prognosis in myocardial ınfarction (C-ALPHA) study. Circulation. 2005;111(7):863–870.
  • Prondzinsky R, Unverzagt S, Lemm H, et al. Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock. Clin Res Cardiol. 2012;101(5):375–384.
  • Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004;17(6):432–437.
  • Roche M, Rondeau P, Singh NR, et al. The antioxidant properties of serum albumin. FEBS Lett. 2008;582(13):1783–1787.
  • Mikhailidis DP, Ganotakis ES. Plasma albumin and platelet function: relevance to atherogenesis and thrombosis. Platelets. 1996;7(3):125–137.
  • Zhao D, Liu Y, Chen S, et al. Predictive value of blood urea nitrogen to albumin ratio in Long-Term mortality in ıntensive care unit patients with acute myocardial ınfarction: a propensity score matching analysis. IJGM. 2022;15:2247–2259.
  • Taniguchi H, Momiyama Y, Ohmori R, et al. Associations of plasma C-reactive protein levels with the presence and extent of coronary stenosis in patients with stable coronary artery disease. Atherosclerosis. 2005;178(1):173–177.
  • Karadeniz M, Duran M, Akyel A, et al. High sensitive CRP level is associated with intermediate and high SYNTAX score in patients with acute coronary syndrome. Int Heart J. 2015;56(4):377–380.
  • Singh U, Dasu MR, Yancey PG, et al. Human C-reactive protein promotes oxidized low density lipoprotein uptake and matrix metalloproteinase-9 release in wistar rats. J Lipid Res. 2008;49(5):1015–1023.
  • Wang CH, Li SH, Weisel RD, et al. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation. 2003;107(13):1783–1790.
  • Fairclough E, Cairns E, Hamilton J, et al. Evaluation of a modified early warning system for acute medical admissions and comparison with C-reactive protein/albumin ratio as a predictor of patient outcome. Clin Med. 2009;9(1):30–33.
  • Çağdaş M, Rencüzoğullari I, Karakoyun S, et al. Assessment of relationship Between C-Reactive protein to albumin ratio and coronary artery disease severity in patients With acute coronary syndrome. Angiology. 2019;70(4):361–368.
  • Vijayan AL, Ravindran S, Saikant R, et al. Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy. J Intensive Care. 2017;5:51.
  • Christ-Crain M, B. Procalcitonin in M. Procalcitonin in bacterial infections-hype, hope, more or less? bacterial infections–hype, hope, more or less?. Swiss Med Wkly. 2005;135(31-32):451–460.
  • Meisner M, Adina H, Schmidt J. Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients. Crit Care. 2006;10(1):R1.
  • Biasucci LM, Biasillo G, Stefanelli A. Procalcitonin and acute coronary syndromes: a new biomarker for an old disease. Intern Emerg Med. 2009;4(5):363–365.
  • Sinning CR, Sinning JM, Schulz A, et al. AtheroGene study ınvestigators association of serum procalcitonin with cardiovascular prognosis in coronary artery disease. Circ J. 2011;75(5):1184–1191.
  • Soylu K, Yuksel S, Gulel O, et al. The relationship of coro-nary flow to neutrophil/lymphocyte ratio in patients undergoingprimary percutaneous coronary intervention. J Thorac Dis. 2013;5:258–264.
  • Sarli B, Baktir AO, Saglam H, et al. Neutrophil-to-lymphocyteratio is associated with severity of coronary artery ectasia. Angiology. 2014;65(2):147–151.
  • Uysal OK, Turkoglu C, Sahin DY, et al. The relationship between neutrophil to lymphocyte ratio and coronary collateral circulation. Clin Appl Thromb Hemost. 2015;21(4):329–333.
  • Şahin DY, Elbasan Z, Gür M, et al. Neutrophil to lymphocyte ratio is associated with the severity of coronary artery disease in patients with ST-segment elevation myocardial infarction. Angiology. 2013;64(6):423–429.
  • Soylu K, Gedikli Ö, Dagasan G, et al. Neutrophil-to-lymphocyte ratio predicts coronary artery lesion complexity and mortality after non-ST-segment elevation acute coronary syndrome. Rev Port Cardiol. 2015;34(7-8):465–471.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.